Please login to bookmark Close
UK biopharmaceutical company Kymab may attack experiments done by US biotechnology giant Regeneron creating genetically modified mice with splices of human genomes, as it defends its proposed patent for a human rat.
Ex-Prime Trust director Wooldridge seeks court approval to manage companies despite recent ban
Please login to bookmark Close
Former health minister and Prime Trust director Michael Wooldridge wants court approval to manage four corporations, despite a recent ruling from the Full Federal Court that reimposed a ban on him and three other former directors of the collapsed retirement village for violations of the Corporations Act.
Western Union manager could not have known no-show employee had mental illness, Full Court says
Please login to bookmark Close
International money transfer giant Western Union has successfully appealed a $160,000 judgment in an employment discrimination case, with the Full Federal Court finding the firm’s HR manager could not have known the employee, who was absent from work for seven months prior to the dismissal, actually suffered from a mental disability.
‘Hostile, aggressive’: Former AMP general counsel alleges bullying in $2.7M lawsuit
Please login to bookmark Close
A former AMP general counsel responsible for preparing the financial giant for the banking royal commission has launched a $2.7 million lawsuit alleging “hostile, aggressive and intimidating behaviour” by superiors in response to formal complaints she made about the company’s fees for no services practices.
Ashley & Martin to refund customers for patchy hair loss treatment
Please login to bookmark Close
The Federal Court has ordered hair loss company Ashley & Martin to refund customers for hair loss treatment they did not receive, after finding three of the company’s standard form contracts contained unfair terms.
Judge rules Myer misled shareholders, backs market-based causation
Please login to bookmark Close
A judge has ruled that department store Myer engaged in misleading or deceptive conduct and breached its continuous disclosure obligations when it failed to correct its “inflated” 2015 net profit forecasts, but said shareholders may not have suffered any loss flowing from the breaches, in a monumental decision that also found investors do not always need to prove direct reliance on misrepresentations in claiming damages in class actions.
ACCC extends review of $350M ANZ, GrainCorp deal
Please login to bookmark Close
The Australian Competition and Consumer Commission has extended its review of ANZ Terminals’ proposed acquisition of a unit of global agribusiness GrainCorp, after expressed competition concerns about the $350 million tie-up in July.
Westpac takes almost $1B hit to cash earnings for customer refunds
Please login to bookmark Close
The costs of Westpac’s customer remediation for the 2019 financial year will approach $1 billion, the bank said Wednesday, as it revealed to the market a $341 million dent in its cash earnings for the second half of the year as part of its ongoing repayment program.
Quintis founder wins unredacted transcripts of ASIC chats with directors
Please login to bookmark Close
Quintis founder Frank Wilson has won his bid for unredacted transcripts of ASIC examinations with six former directors of the failed sandalwood company.
High Court to hear Securency appeal after $65M ‘shabby fraud’ award slashed
Please login to bookmark Close
The High Court has granted a Nigerian agent tricked into terminating his contract with international bank note manufacturer CCL Secure special leave to appeal a Full Federal Court judgment slashing a $65 million award in his favour.